References
- Terjanin T, Kantarjian H, Keating M, Talpaz M, Mccredie K, Freireich EJ. Clinical and prognostic features of patients with Philadelphia chromosome-positive chronic myelogenous leu-kemia and extramedullary disease. Cancer 1987;59:297 —300.
- Cervantes F, Rozman M, Nicolas JM, Lopez Guillermo A, Rozman C. Extramedullary blast crisis in chronic myeloid leukemia. Sangre (Barc) 1989;34:96–98.
- Millot F, Facon T, Kerckaert JP et al. Unusual recurrence of chronic myelogeneous leukemia following bone marrow transplantation. Bone Marrow Transplant 1991;7:393–395.
- Webb M, Meyer B, Jackson JM, Davies JM. Localized relapse of chronic myeloid leukaemia post allogeneic bone marrow transplantation. Br J Haematol 1993;84:178–181.
- Bekassy AN, Hermans J, Gorin NC, Gratwohl A for the Acute and Chronic Leukemia Working Parties of the European Group for Blood and Marrow Transplantation. Granulocytic sarcoma after allogeneic bone marrow transplantation: a retrospective European multicenter survey. Bone Marrow Transplant 1996;17:801— 808.
- Sawyers CL, Hochhaus A, Feldman E et al. Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study. Blood 2002;99:3530 — 3539.
- Jacknow G, Frizzera, G, Gajl-Peczalska K, et al. Extramedul-lary presentation of the blast crisis of chronic myelogenous leukemia. Br J Haematol 1985;61:225–236.
- Neiman RS, Barcos M, Berard C et al. Granulocytic sarcoma: a clinicopathologic study of 61 biopsied cases. Cancer 1981;48:1426–1437.
- Mori T, Yamazaki R, Ikeda Y, Okamoto S. Fluorescence in situ hybridization for the BCR-ABL fusion gene in a patient with imatinib mesylate-resistant chronic myelogenous leuke-mia in extramedullary blast crisis. Br J Haematol 2003;121:533.
- Miksanek T, Reyes CV, Semkiw Z, Molnar ZJ. Granulocytic sarcoma of the peritoneum. CA Cancer J Chin 1983;33:40 — 42.
- O'Brien SG, Guilhot F, Larson RA et al. for the IRIS investigators. Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia. N Engl J Med 2003;348:994— 1004.
- Druker BJ, Sawyers CL, Kantarjian H et al. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with Philadelphia chromosome. N Engl J Med 2001;344:1038–1042.
- Naito K, Mori T, Miyazaki K, Tsukada Y, Ikeda Y, Okamoto S. Successful treatment of extramedullary blast crisis of chronic myelogeneous leukemia with imatinib mesylate (STI571). Intern Med 2003;42:740— 742.